[ET Net News Agency, 27 September 2024] TIGERMED (03347) rose 9.5% to HK$34, breaking
above the 250-D SMA of HK$32.517.
It hits an intra-day high of HK$34.2, hitting an 1-month high, and an intra-day low of
HK$31.55. The total shares traded was 1.77 million, with a value of HK$57.95m. The active
buy/sell ratio is 54:46, with net buying turnover of HK$4.89m. GUOSEN SEC (HK) accounts
for greatest net responsive buying turnover of HK$813,240, with volume weighted average
price of HK$32.4. LUK FOOK SEC HK accounts for greatest net responsive selling turnover of
HK$2.23m, with volume weighted average price of HK$32.245. The stock has risen a combined
27.8% over the past 4 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 34.000 % Chg +9.50%
High 34.200 Low 31.550
Shares Tr 1.77m Turnover 57.95m
10-D SMA 28.060 %H.V 55.733
20-D SMA 27.715 VWAP 32.689
50-D SMA 29.584 RSI14 70.569
---------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
54:46, with net buying turnover of HK$4.89m, rising a combined 27.8% over the past 4
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
TIGERMED (03347) 34.00 +9.50
HUTCHMED (00013) 30.70 +8.87
GENSCRIPT BIO (01548) 13.00 +15.04
INNOVENT BIO (01801) 47.30 +5.58
JXR (01951) 3.10 +9.15
WUXI XDC (02268) 23.45 +14.67
WUXI BIO (02269) 15.74 +13.56
BEIGENE (06160) 132.90 +3.50
SKB BIO-B (06990) 173.50 +2.48
AKESO (09926) 69.35 +8.44
---------------------------------------------
(ed)